N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺结构式
|
常用名 | N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 | 英文名 | N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|---|---|---|---|---|
| CAS号 | 477600-74-1 | 分子量 | 245.324 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C13H19N5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
|---|---|
| 英文名 | N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| 中文别名 | N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺 | n-甲基-n-[(3r,4r)-4-甲基-3-哌啶基]-7H-吡咯并[2,3-d]嘧啶-4-胺 | 托伐替尼杂质M |
| 英文别名 | 更多 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 分子式 | C13H19N5 |
| 分子量 | 245.324 |
| 精确质量 | 245.164047 |
| PSA | 56.84000 |
| LogP | 1.54 |
| 折射率 | 1.637 |
| 储存条件 | 2-8°C,避光,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|
|
~92%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
|
~%
N-甲基-N-((3R,4R)... 477600-74-1 |
| 文献:Tetrahedron Letters, , vol. 54, # 37 p. 5096 - 5098 |
| N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- |
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| Tofacitinib Impurity M |